Provided by Tiger Trade Technology Pte. Ltd.

Ashland

63.04
-1.7600-2.72%
Post-market: 63.040.00000.00%16:10 EST
Volume:861.19K
Turnover:54.43M
Market Cap:2.88B
PE:-4.17
High:64.32
Open:63.70
Low:62.11
Close:64.80
52wk High:66.40
52wk Low:45.21
Shares:45.76M
Float Shares:41.77M
Volume Ratio:0.99
T/O Rate:2.06%
Dividend:1.65
Dividend Rate:2.62%
EPS(TTM):-15.1257
EPS(LYR):-18.3696
ROE:-29.98%
ROA:2.09%
PB:1.54
PE(LYR):-3.43

Loading ...

Ashland Is Maintained at In-Line by Evercore ISI Group

Dow Jones
·
Nov 11, 2025

Shield Therapeutics to Present Pediatric PK Results at ASH Conference

TIPRANKS
·
Nov 11, 2025

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 10, 2025

Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST)

GlobeNewswire
·
Nov 10, 2025

Galecto Announces Acquisition of Damora Therapeutics

GlobeNewswire
·
Nov 10, 2025

Press Release: ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025

Dow Jones
·
Nov 07, 2025

Evercore ISI Sticks to Its Hold Rating for Ashland (ASH)

TIPRANKS
·
Nov 06, 2025

Ashland Global’s Resilient Earnings Amid Challenges

TIPRANKS
·
Nov 06, 2025

Stock Track | Ashland Soars 5.10% Despite Q4 Sales Decline as Margins Improve

Stock Track
·
Nov 06, 2025

Stock Track | Ashland Soars 5.10% Despite Q4 Sales Decline as Margins Improve

Stock Track
·
Nov 06, 2025

HK Stock Movement | LEADS BIOLABS-B (09887) Rises Over 3% as Five Hematology Research Findings Presented at 2025 ASH Annual Meeting

Stock News
·
Nov 05, 2025

Ashland Reports Q4 2025 Results Amid Sales Decline

TIPRANKS
·
Nov 05, 2025

Ashland reports Q4 adjusted EPS $1.08, consensus $1.26

TIPRANKS
·
Nov 05, 2025

Ashland sees FY26 revenue $1.835B-$1.905B, consensus $1.87B

TIPRANKS
·
Nov 05, 2025

Ashland Q4 Adj. EPS $1.08 Misses $1.24 Estimate, Sales $478.000M Miss $480.553M Estimate

Benzinga
·
Nov 05, 2025

BRIEF-Ashland Q4 Revenue USD 478 Million Vs. IBES Estimate USD 480.1 Million

Reuters
·
Nov 05, 2025

Ashland Inc: Targets to Achieve About $30 Mln in Cost Savings Under $90 Mln Program in 2026

THOMSON REUTERS
·
Nov 05, 2025

Ashland Inc Outlook FY Adj EPS Excluding Intangibles Amortization Expense Growth Double-Digit-Plus

THOMSON REUTERS
·
Nov 05, 2025

Ashland Q4 Free Cash Flow USD 52 Million

THOMSON REUTERS
·
Nov 05, 2025

Ashland Outlook FY Adjusted Ebitda USD 400-430 Million

THOMSON REUTERS
·
Nov 05, 2025